Simris Alg AB Class B (5LU) Price & Analysis

Q: What was Simris Alg AB Class B’s price range in the past 12 months?

Simris Alg AB Class B lowest stock price was <€0.01 and its highest was €0.02 in the past 12 months.

Q: What is Simris Alg AB Class B’s market cap?

Simris Alg AB Class B’s market cap is €11.68M.

Q: When is Simris Alg AB Class B’s upcoming earnings report date?

Simris Alg AB Class B’s upcoming earnings report date is Nov 11, 2026 which is in 75 days.

Q: How were Simris Alg AB Class B’s earnings last quarter?

Simris Alg AB Class B released its earnings results on Aug 12, 2026. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

0 Followers

5LU Stock Chart & Stats

€0.01

<€0.01(90.00%)

At close: Nov 15 4:00 PM EST

€0.01

<€0.01(90.00%)

Day’s Range― - ―

52-Week Range<€0.01 - €0.02

Previous CloseN/A

Volume5.00K

Average Volume (3M)2.50K

Market Cap

€11.68M

Enterprise Value€205.61

Total Cash (Recent Filing)€7.99M

Total Debt (Recent Filing)€89.69M

Price to Earnings (P/E)―

Beta-2.41

Next Earnings

Nov 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.03

Shares Outstanding1,349,793,200

10 Day Avg. Volume6,500

30 Day Avg. Volume2,500

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)-76.69

Price to Sales (P/S)22.32

P/FCF Ratio-2.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improving Net ResultThe modest improvement in net losses suggests some progress compared with 2025. If sustained through better cost control or product economics, it could support gradual stabilization, although current profitability remains deeply negative.

Positive EPS GrowthReported EPS growth indicates earnings performance improved from the prior comparison period. This may provide an initial signal of operating progress, but the benefit is limited because the company remains loss-making and lacks supporting guidance.

Microalgae Platform ExposureA focus on microalgae cultivation and algae-derived ingredients gives the company exposure to biotechnology and nutrition applications. This platform could support multiple product or ingredient formats over time, though commercial traction is not established.

Bears Say

Contracting Revenue And Negative MarginsFalling revenue combined with negative gross profit indicates the business is not yet covering direct production costs. Persistent operating losses weaken the prospects for self-funded growth and suggest that a durable path to profitability remains unproven.

Extreme Leverage And Minimal EquityNear-zero equity and very high debt leave little balance-sheet flexibility for a loss-making biotech. The capital structure increases refinancing and dilution risk, while limiting the company’s ability to absorb setbacks or fund expansion internally.

Persistent Cash BurnNegative operating and free cash flow show that core activities continue to consume cash. Without a material improvement in margins or working capital, the company is likely to remain dependent on external funding to sustain operations and pursue development.

5LU FAQ

What was Simris Alg AB Class B’s price range in the past 12 months?

Simris Alg AB Class B lowest stock price was <€0.01 and its highest was €0.02 in the past 12 months.

What is Simris Alg AB Class B’s market cap?

Simris Alg AB Class B’s market cap is €11.68M.

When is Simris Alg AB Class B’s upcoming earnings report date?

Simris Alg AB Class B’s upcoming earnings report date is Nov 11, 2026 which is in 75 days.

How were Simris Alg AB Class B’s earnings last quarter?

Simris Alg AB Class B released its earnings results on Aug 12, 2026. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Simris Alg AB Class B overvalued?

According to Wall Street analysts Simris Alg AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Simris Alg AB Class B pay dividends?

Simris Alg AB Class B does not currently pay dividends.

What is Simris Alg AB Class B’s EPS estimate?

Simris Alg AB Class B’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Simris Alg AB Class B have?

Simris Alg AB Class B has 1,349,793,200 shares outstanding.

What happened to Simris Alg AB Class B’s price movement after its last earnings report?

Simris Alg AB Class B reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 100%.

Which hedge fund is a major shareholder of Simris Alg AB Class B?

Currently, no hedge funds are holding shares in DE:5LU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Simris Alg AB Class B

Operating both within Sweden and across global markets, Simris Alg AB (publ) specializes in the production and sale of nutritional supplements and food products derived from algae. Its product portfolio includes Simris Algae Omega-3, a unique plant-derived marine omega-3 supplement providing both EPA and DHA. Additionally, under its 'Simris Select' brand, the company provides a range of other algae-based items like premium chlorella, spirulina sprinkles, invigorating astaxanthin, and various algae teas such as 'flower power' and 'sun candy'. Established in 2010, the firm maintains its main office in Hammenhög, Sweden.